{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Piritrexim",
  "nciThesaurus": {
    "casRegistry": "72732-56-0",
    "chebiId": "",
    "chemicalFormula": "C17H19N5O2",
    "definition": "A synthetic antifolate agent with antiparasitic, antipsoriatic and antitumor properties. Piritrexim inhibits the enzyme dihydrofolate reductase enzyme, thereby disrupting folate metabolism and DNA synthesis and cell division.",
    "fdaUniiCode": "MK2A783ZUT",
    "identifier": "C1031",
    "preferredName": "Piritrexim",
    "semanticType": "Organic Chemical",
    "subclassOf": [
      "C2153",
      "C511"
    ],
    "synonyms": [
      "2,4-Diamino-6-(2,5-dimethoxybenzyl)-5-methylpyrido[2,3-d]pyrimidine",
      "6-((2,5-Dimethoxyphenyl)methyl)-5-methylpyrido(2,3-d)pyrimidine-2,4-diamine",
      "6-[(2,5-Dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d]pyrimidine-2,4-diamine",
      "BW 301U",
      "BW-301U",
      "PIRITREXIM",
      "Piritrexim",
      "piritrexim"
    ]
  }
}